Japan Scientists Combine Statins, iPS Cells For Bone Disease
This article was originally published in PharmAsia News
Executive Summary
Japan researchers suggest combining anti-cholesterol statin drugs with a stem cell treatment could aid patients with skeletal dysplasia, a genetic bone disease.